본문 바로가기
KERD
논문KCI 등재

신생아 약동학과 약물요법

Pharmacokinetics and drug therapy in neonates

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

.

Abstract

Neonates include both full term and preterm infants up to 28 days of age. The heterogeneity and rapid physiologic change of neonates affect all aspects of pharmacokinetics such as absorption, distribution, metabolism, and elimination. This feature should be considered in determining the dose and regimen of drug therapy in neonates. However, the research on the safety and efficacy of specific drugs is limited due to ethical and technical issues. This review article focuses on the neonatal pharmacokinetics and the rationales of drug therapy in neonates based on findings of previous studies and empirical evidence.

참고문헌 (48)

  1. Ward RM, "Avery’s neonatology", pp.1093~1103 (2016), Wolters Kluwer
  2. Tayman C, "Neonatal pharmacology:extensive interindividual variability despite limited size", J Pediatr Pharmacol Ther, 16, pp.170~184 (2011)
  3. Morselli PL, "Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications", Clin Pharmacokinet, 5, pp.485~527 (1980)
  4. Peterson RG, "Pharmacology of furosemide in the premature newborn infant", J Pediatr, 97, pp.139~143 (1980)
  5. Lowry JA, "Nelson textbook of pediatrics", pp.404~416 (2016), Elsevier
  6. Kearns GL, "Developmental pharmacolog:drug disposition, action, and therapy in infants and children", N Engl J Med, 349, pp.1157~1167 (2003)
  7. De Luca D, "Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review", Eur Respir J, 37, pp.678~689 (2011)
  8. Rutter N, "Percutaneous drug absorption in the newborn:hazards and uses", Clin Perinatol, 14, pp.911~930 (1987)
  9. Aranda JV, "Pharmacokinetic aspects of theophylline in premature newborns", N Engl J Med, 295, pp.413~416 (1976)
  10. Ku LC, "Dosing in neonates: special considerations in physiology and trial design", Pediatr Res, 77, pp.2~9 (2015)
  11. Samardzic J, "Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period", Expert Opin Drug Metab Toxicol, 12, pp.367~375 (2016)
  12. Pauwels S, "Therapeutic drug monitoring in neonates", Arch Dis Child, 101, pp.377~381 (2016)
  13. Baley JE, "Fanaroff and Martin’s neonatal-perinatal medicine: diseases of the fetus and infant", pp.782~833 (2015), Elsevier
  14. Barben J, "Current management of acute bronchiolitis in Switzerland", Swiss Med Wkly, 133, pp.9~15 (2003)
  15. Flores G, "Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis", Pediatrics, 100(2 Pt 1), pp.233~239 (1997)
  16. Gadomski AM, "Bronchodilators for bronchiolitis", Cochrane Database Syst Rev, (6), pp.CD001266~ (2014)
  17. Ralston SL, "Clinical practice guideline:the diagnosis, management, and prevention of bronchiolitis", Pediatrics, 134, pp.e1474~e1502 (2014)
  18. Patel H, "Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mildto-moderate acute viral bronchiolitis", J Pediatr, 142, pp.509~514 (2003)
  19. Hartling L, "Epinephrine for bronchiolitis", Cochrane Database Syst Rev, (6), pp.CD003123~ (2011)
  20. Hartling L, "Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis", BMJ, 342, pp.d1714~ (2011)
  21. Fernandes RM, "Glucocorticoids for acute viral bronchiolitis in infants and young children", Cochrane Database Syst Rev, (6), pp.CD004878~ (2013)
  22. Flores-Gonzalez JC, "Epinephrine improves the efficacy of nebulized hypertonic saline in moderate bronchiolitis: a randomised clinical trial", PLoS One, 10, pp.e0142847~ (2015)
  23. Brooks LJ, "Theophylline therapy in bronchiolitis. A retrospective study", Am J Dis Child, 135, pp.934~936 (1981)
  24. Lee JH, "Respiratory syncytial virus related readmission in preterm infants less than 34 weeks’ gestation following discharge from a neonatal intensive care unit in Korea", J Korean Med Sci, 30(Suppl 1), pp.S104~S110 (2015)
  25. Abraha HY, "Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention", Expert Rev Respir Med, 9, pp.779~799 (2015)
  26. American Academy of Pediatrics Committee on Infectious Diseases, "Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection", Pediatrics, 134, pp.e620~e638 (2014)
  27. Wu S, "Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial", JAMA Pediatr, 168, pp.657~663 (2014)
  28. Baron J, "Hypertonic saline for the treatment of bronchiolitis in infants and young children: a critical review of the literature", J Pediatr Pharmacol Ther, 21, pp.7~26 (2016)
  29. Zhang L, "Nebulized hypertonic saline for acute bronchiolitis: a systematic review", Pediatrics, 136, pp.687~701 (2015)
  30. Stoll BJ, "Nelson textbook of pediatrics", pp.909~925 (2016), Elsevier
  31. Atkinson LR, "Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline?", Pediatrics, 111(5 Pt 1), pp.e555~e561 (2003)
  32. Kaplan M, "Fanaroff and Martin’s neonatal-perinatal medicine: diseases of the fetus and infant", pp.1618~1673 (2015), Elsevier
  33. Honar N, "Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy", J Pediatr Gastroenterol Nutr, 62, pp.97~100 (2016)
  34. McClary JD, "Fanaroff and Martin’s neonatalperinatal medicine: diseases of the fetus and infant", pp.1810~1815 (2015), Elsevier
  35. Maisels MJ, "Avery’s neonatology", pp.587~645 (2016), Wolters Kluwer
  36. 신재원, "Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures", Clinical and Experimental Pediatrics, 60(2), pp.50~54 (2017), 대한소아청소년과학회
  37. Hibbs AM, "Fanaroff and Martin’s neonatalperinatal medicine: diseases of the fetus and infant", pp.1371~1378 (2015), Elsevier
  38. D’Agostino JA, "Use of gastroesophageal reflux medications in premature infants after NICU discharge", Pediatrics, 138, pp.e20161977~ (2016)
  39. Guillet R, "Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants", Pediatrics, 117, pp.e137~e142 (2006)
  40. Bianconi S, "Ranitidine and late-onset sepsis in the neonatal intensive care unit", J Perinat Med, 35, pp.147~150 (2007)
  41. Orenstein SR, "Famotidine for infant gastrooesophageal reflux: a multi-centre, randomized, placebocontrolled, withdrawal trial", Aliment Pharmacol Ther, 17, pp.1097~1107 (2003)
  42. Hibbs AM, "Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review", Pediatrics, 118, pp.746~752 (2006)
  43. Djeddi D, "Effect of domperidone on QT interval in neonates", J Pediatr, 153, pp.663~666 (2008)
  44. Gunlemez A, "Effect of domperidone on the QTc interval in premature infants", J Perinatol, 30, pp.50~53 (2010)
  45. Kim SH, "Hyponatremia and generalized edema associated with ibuprofen therapy in a neonate", J Korean Soc Neonatol, 13, pp.176~179 (2006)
  46. Pacifici GM, "Clinical pharmacology of paracetamol in neonates: a review", Curr Ther Res Clin Exp, 77, pp.24~30 (2015)
  47. Bucaretchi F, "Acute liver failure in a term neonate after repeated paracetamol administration", Rev Paul Pediatr, 32, pp.144~148 (2014)
  48. Walls L, "Acetaminophen-induced hepatic failure with encephalopathy in a newborn", J Perinatol, 27, pp.133~135 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (4건)